News Sentiment

ADPT sentiment intelligence

Adaptive Biotechnologies Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 51 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 21.06 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

85/100 classification confidence.

Company focus 51

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-0.6% over one week, +19.7% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Adaptive Biotechnologies schedules May 5 webcast for Q1 2026 results

Market Reaction

Balanced read

50/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 85/100 classification
One-week reaction -0.6% Price digesting
Trend fit Trend active 19.7% over four weeks
Fair value 137.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 38
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 51
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 17
simplywall.st 5
MT Newswires 4
TradingView 4
Market source 4
Investing.com 3
Investing.com South Africa 3
The Motley Fool 2

Event Lens

What the news is about

Classified themes
Market update 37
Earnings 8
Balance sheet 2
Analyst action 2
Regulatory and legal 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-51 of 51
Investing.com Australia Direct company coverage

Form 4 Adaptive Biotechnologies Corp For: 30 June By Investing.com

This article reports on the filing of Form 4 for Adaptive Biotechnologies Corp for the period ending June 30. It focuses solely on this regulatory filing, indicating an insider transaction or change in ownership that companies are required to disclose. The article is very brief,

Tone
Neutral 50/100
Event
Regulatory and legal
Published
01 Jul 2026 08:38
Source
Investing.com Australia
Stock Titan Direct company coverage

Adaptive Biotechnologies (ADPT) CCO trades shares under 10b5-1 plan

Sharon Benzeno, Chief Commercial Officer for Immune Medicine at Adaptive Biotechnologies (ADPT), exercised stock options and sold a total of 165,802 shares in open-market transactions on June 26 and 29, 2026. These transactions, executed under a pre-arranged Rule 10b5-1 trading p

Tone
Negative 36/100
Event
Market update
Published
01 Jul 2026 08:38
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Form 4 Adaptive Biotechnologies Corp For: 29 June By Investing.com

This article from Investing.com reports on a Form 4 filing for Adaptive Biotechnologies Corp (ADPT) for June 29. The brief piece indicates insider trading activity for the company on the specified date.

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 01:11
Source
Investing.com Nigeria
Investing.com South Africa Direct company coverage

Adaptive Biotechnologies director Michelle Griffin sells $1.05m stock By Investing.com

Adaptive Biotechnologies Director Michelle Renee Griffin sold 52,084 shares of common stock for over $1 million, executed under a pre-arranged trading plan after exercising stock options. This sale occurred while the stock was trading near its 52-week high, following an 81.5% sur

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 00:09
Source
Investing.com South Africa